The first batch of COVID-19 vaccines purchased from Sinopharm laboratory —consisting of one million doses— will arrive on February 9, 2021, Peruvian President Francisco Sagasti
confirmed on Sunday.
The Head of State explained that this first batch is part of an agreement signed with said Chinese laboratory to supply a total of 38 million doses of the COVID-19 vaccine to Peru.
Additionally, he reported that arrangements have been made so that COVAX Facility can deliver a batch of doses, probably of Pfizer and AstraZeneca vaccines, in the first quarter of this year.
The statesman indicated that the Peruvian Government is in the final stages of the negotiation with Pfizer for the supply of 9.9 million doses.
Likewise, he noted that Peru has already signed an agreement with AstraZeneca to procure 14 million doses, which will be available starting September 2021.
Moreover, the Peruvian leader emphasized that negotiations with Pfizer, Johnson & Johnson, and Moderna are advanced.
"All this means that Peru will have access to the necessary vaccines to protect its population in 2021," he assured.
In this sense, Mr. Sagasti affirmed that vaccines are the most effective way to prevent all diseases and that, thanks to medical science, there is a vaccine to tackle COVID-19.
Remarks were made in a televised Address to the Nation on Sunday morning.